The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation

Sponsor
Wissenschaftliches Institut Bethanien e.V (Other)
Overall Status
Completed
CT.gov ID
NCT03506906
Collaborator
(none)
105
1
2
22.3
4.7

Study Details

Study Description

Brief Summary

Patients suffering chronic hypercapnic respiratory insufficiency (e.g. in chronic obstructive pulmonary disease, obesity hypoventilation syndrome) benefit from home mechanical ventilation. These patients are complex; and the ventilator´s parameters should be set-up according to the underlying disease and particular patient's characteristics. The non-invasive ventilation therapy is mostly titrated while the patient is awake, hence Problems, such as Patient-Ventilator asynchrony, arising while sleeping on the ventilator therapy would remain undetected.

Sleep studies, such as polysomnography or polygraphy and transcutaneous carbon dioxide monitoring could be valuable tools to fine-tune the ventilator's settings. This could foster the ventilator´s effectivity and patient satisfaction, thus therapy's adherence. Nevertheless the sleep studies are expensive, time-consuming and not widely available.

The aim of this study is to learn the findings of sleep studies when they are performed on stable patients on home mechanical ventilation as part of their routine check-ups. In this context, it will be assessed whether the sleep studies' findings lead to a change (adjustment) of the ventilator´s therapy. Moreover, this study aims to investigate whether the absence of sleep studies would result in missing important events that require an adjustment of therapy. The results of this study could provide information that lead to a more standardized protocol of follow-up checks of patients on home mechanical ventilation in a cost-effective manner.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Sleep studies under noninvasive ventilation therapy
  • Diagnostic Test: Routine tests
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
105 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation
Actual Study Start Date :
Nov 11, 2018
Actual Primary Completion Date :
Sep 25, 2019
Actual Study Completion Date :
Sep 21, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional-approach

The non-invasive ventilation therapy will be optimized according to routine tests (blood gas analysis, lung function, ventilator's built-in software analysis)

Diagnostic Test: Routine tests
Spirometry, six minute walk test, blood gas analysis, questionnaires (Epworth sleepiness score, health related quality of life severe respiratory insufficiency questionnaire)

Experimental: Sleep studies-based approach

Additionally to the routine tests, the results of a nocturnal polysomnography and transcutaneous capnometry under the non-invasive ventilation therapy will be considered for the therapy optimization.

Diagnostic Test: Sleep studies under noninvasive ventilation therapy
Polysomnography Transcutaneous capnography

Diagnostic Test: Routine tests
Spirometry, six minute walk test, blood gas analysis, questionnaires (Epworth sleepiness score, health related quality of life severe respiratory insufficiency questionnaire)

Outcome Measures

Primary Outcome Measures

  1. Adjustment of non-invasive ventilation [One day]

    Each case will be evaluated separately by 2 investigators. One of them will be provided with the diurnal evaluations only (as routinely); the second investigator will additionally have access to the sleep studies. Each investigator will classify the case as one of the following labels (primary outcome): Non-invasive ventilation therapy optimization is not required (all ventilator's parameters should stay unchanged) Optimization of non-invasive ventilation therapy is required (one or more of the ventilator's parameters should be re-set, irrespective of the magnitude)

Secondary Outcome Measures

  1. Non-invasive ventilation compliance [6 months]

    The ventilator's optimization will be performed randomly according to the clinical-based approach or the sleep studies-based approach. In the next follow-up visit, both arms will be re-evaluated. The change in non-invasive ventilation therapy compliance will be explored based on the ventilator´s built-in software data.

  2. Health-related quality of life: questionnaire [6 months]

    In the next follow-up visit, the health-related quality of life of both groups will be evaluated with the severe respiratory insufficiency questionnaire.

  3. arterial level of carbon dioxide [6 months]

    In the next follow-up visit, the arterial level of carbon dioxide of both groups will be evaluated in the blood gas analysis

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with chronic hypercapnic respiratory failure secondary to one or more identified condition(s) (chronic obstructive pulmonary disease, obesity hypoventilation syndrome, neuromuscular diseases, restrictive lung diseases)

  • Home mechanical ventilation for ≥ 6 months

  • Stable condition for ≥ 1 month

Exclusion Criteria:
  • Previous adjustment of the noninvasive ventilation therapy under sleep studies in the last 6 months

  • Current respiratory exacerbation

  • Any current comorbidity decompensation

  • Any medical or psychological condition impairing the patient's ability to provide informed consent

  • Missing signed informed consent

  • Total sleep time during polysomnography <180 min

Contacts and Locations

Locations

Site City State Country Postal Code
1 Krankenhaus Bethanien Solingen NRW Germany 42699

Sponsors and Collaborators

  • Wissenschaftliches Institut Bethanien e.V

Investigators

  • Principal Investigator: Winfried J Randerath, Prof. Dr., Krankenhaus Bethanien

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wissenschaftliches Institut Bethanien e.V
ClinicalTrials.gov Identifier:
NCT03506906
Other Study ID Numbers:
  • WI_18-023
First Posted:
Apr 24, 2018
Last Update Posted:
Oct 7, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wissenschaftliches Institut Bethanien e.V
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 7, 2021